Hamdard Institute of Medical Sciences & Research (HIMSR)
Search
HIMSR PG (MD/MS) Admission

Doctor's Profile

Dr. Kailash Chandra

MSc, Ph.D. (Medical Biochemistry), MNAMS

Associate professor, Department of Biochemistry

Reg. Number: N/A

drkailashchandra@himsr.co.in

About

Dr. Kailash Chandra has obtained his M.Sc. Medical Biochemistry from Kumaun University Nainital, UK and Ph.D. (Medical Biochemistry) from Jamia Hamdard, New Delhi. He has more than 15 years of Post-PG research and teaching experience and has a number of papers published in National and International Journals of high repute. He is trained in various research techniques used in biomedical research. His specialization is in Biochemical, phytochemical and Molecular Biology techniques with expertise in cell lines, animal and human trials. As a student he had a deep interest in understanding the role of traditional medicines in metabolic disorders. Therefore, he has selected the problem of insulin resistance and undertook an in depth study of the role of Cichorium intbyus seeds. They have proved the beneficial effect of Cichorium intbyus seeds in diabetes mellitus by animal and human studies. For this, the study group has filed a patent to Indian Patent office that entitled ‘A Natural Phytochemical Dietary Supplement for Prevention, Treatment, and Management of Diabetes Mellitus. Cellular and molecular pharmacology with special interest in herbs, discovery of biomarkers and AGE-RAGE signaling study in diabetic kidney disease are the potential area where my research group is currently working.

Educational Qualifications

S.No. Degree Year of Completion Institute Name
1 Ph.D. in Medical Biochemistry 2019 Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi.
2 M.Sc. Medical Biochemistry 2008 Government Medical College Haldwani (IAHSET), Nainital. Uttrakhand

Details of Teaching Experience

S.No. Designation Institution From To Duration
1 Associate Professor HIMSR, New Delhi 10-01-2024 Present
2 Assistant Professor HIMSR, New Delhi 11-06-2019 09-01-2024 4 Years, 6Months
3 Demonstrator HIMSR, New Delhi 13-12-2010 10-06-2019 8 years, 5 months

Publications (Last Three Years)

  1. Nabi, N., Manghani, A., Uddin, A., Dhillon N., Singh D., Chandra K., Jain V., Jain R., Ahmad R., Kohli S. Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi. Cost Eff Resour Alloc 23, 33 (2025). IF-2.1 (Indexed in Scopus/Pubmed).
  2. Chandra K*, Aalam SK, Khan AMA, Londhe S, Sirur SP, Chaudhari M, Pandit Y, Mueed A, Ranjan R, Agarwal S, and Joshi SK. Efficacy and safety of polyherbal formulation in the management of acne vulgaris: An open label, baseline-controlled, single center, prospective clinical trial, Advances in Integrative Medicine, 2025,12;03:100490, Published online (Indexed in Scopus/Pubmed). IF-1.3
  3. Suyal, M., Khan, A.M.A., Nabi, N. Sultana F, Gupta P., Ansari MA, Gautam R, Kapur P, Kohli S., Chandra K*. Beyond Bone Health: Does Higher Vitamin D Augment Oxidative Stress in Children?. Indian J Pediatr; 2025; 92;5:546 IF-2.8 (Indexed in Scopus/EMBASE).
  4. Imam M, Khan AMA, Suyal M , Zahiruddin S ,Jain V, Ahmad S , and Chandra K*. Characterization of Amino Acid Composition, Nutritional Value, and Glycemic Index Study of Eleusine coracana Grains: A Functional Food for Diabetes Management. Journal of Food Quality; 2025; Volume 2025, Article ID 7758886, 10 pages. . IF-3.3 (Indexed in Scopus/DOAJ).
  5. Agarwal S., Arif R, Singh K, McGregor L, Tomar V., Mueed S., Joshi SK., Chandra K., Anurag, Sharma A., Investigating the volatilome of sandalwood powder using comprehensive two dimensional gas chromatography coupled with time-of-flight mass spectrometry. SEEJPH. 2025;XXVI, S2:1054-1065. ISSN: 2197-5248 (Indexed in Scopus).
  6. Iqbal J, Monga S, Agarwal D, Rasool S and Chandra K, Assessment of Change in cytokine and chemokine profile with antioxidant therapy in Allergic Rhinitis. Res. J. Med. Sci. 2025, 19: 444‐450 doi: 10.36478/ makrjms.2025.1.444.450. (Indexed in Scopus/EMBASE).
  7. Shamim S, Alam O, Jha M, Nazar S, Mathur V, Ali S, Iliyas A, Chandra K, Jamil Ahmed SMA, Naim MJ, Parveen B. Triazole scaffold-based DPP-IV Inhibitors for the management of Type-II Diabetes Mellitus: Insight into Molecular Docking and SAR. Curr Top Med Chem. 2024 Oct 31. doi: 10.2174/0115680266339313241021053225. Online ahead of print. IF-3.57
  8. Kaur J, Azad F, Khan AMA, Farzaan M, Ahmad J, Farooqi H, Chandra K, Panda BP. In-vitro modulation of glucose and lipid metabolism by Lentinula edodes extracts in obesity and type 2 diabetes models. Pharmacological Research-Modern Chinese Medicine. 2024; 13: 100540.
  9. Sharma T, Goyal B, Ahmed KA, Deo G, Kaushik I, Malik R, Jain V., Singh D., Kohli S., and Chandra K*. Efficacy of standardized yoga asanas as add‑on therapy in the management of hypothyroidism: A randomized, open‑label, controlled clinical study. Int J Yoga, 2024;17:124-31 ((Impact factor 1.6/Pubmed).
  10. Khan AMA, Nabi N, Abdi G, Jain V, Singh D, Alam O, Ahmad S, Chandra K*. Human Pancreatic β Cell Regenerative Therapy: Exploring the Role of Chicoric Acid as a Phytochemical Candidate. J Phytopharmacol 2024; 13(2):105-113. doi: 10.31254/phyto.2024.13204.
  11. Khan AMA, Chandra K*. Medicinal and Nutritional Importance of Cichorium intybus in human health (Chapter 13). Book- Medicinal plants and their bioactive compounds in human health, Volume 1. Page. 255-271, Publisher-Springer (ebook-ISBN978-981-97-6895-0, Print ISBN- 978-981-97-6894-3), 2024.
  12. Kaur J., Farooqi H., Chandra K., Panda B P. Predicting the bioactive compounds of Lentinula edodes and elucidating its interaction with genes associated to obesity through network pharmacology and in-vitro cell-based assay. Heliyon, 2024;10 (5), E27363CH. IF- 4.0.
  13. Jain V, Bajaj K, Neelamegam S, Singh D, Chandra K, Kashyap V et al. Acute respiratory distress syndrome in plasmodium vivax malaria. A case-control study of comparison between ARDS and non-ARDS patients in P. Vivax malaria. Int J Res Med Sci 2023; 11:2935-41.
  14. Jain V., Nabi N, Aggarwal S , Alam Z, Chandra K* , Singh D*, Kashyap V, Islam F, Kohli S. Long‐term health consequences of COVID‐19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID‐19 severity and associated risk factors. Journal of Clinical Nursing. 2024, 33(1):115-125 (Impact factor 4.4)
  15. Firdaus J, Siddiqui N, Alam O, Manaithiya A, Chandra K. Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis. Arch. Pharm. 2023, e2200421. https://doi.org/10.1002/ardp.202200421. (Impact factor 4.7).
  16. Jannat ul Firdaus, Nadeem Siddiqui, Ozair Alam, Ajay Manaithiya & Kailash Chandra. Identification of novel pyrazole containing ɑ-glucosidase inhibitors: insight into pharmacophore, 3D-QSAR, virtual screening, and molecular dynamics study, Journal of Biomolecular Structure and Dynamics. 2022 (online published) DOI: 10.1080/07391102.2022.2141893 (Impact factor 5.23).
  17. Modi M, Nandi K, Jain V, Chandra K*. A Comprehensive Stability Study of Glucose Concentrations Measured in Sodium Fluoride, Heparin and Serum Separator Tubes: A Cross-sectional Study. National journal of Laboratory Medicine. 2022 (in-press).
  18. Chandra K, Das AK, Banday S, Dhyani N, Upadhyay B, Dang A, Joshi S, Dudeja M. Phenotyping of lymphocyte subsets, Th 1/Th 2 cytokines and other parameters in high risk contacts of SARS CoV 2. Indian Journal of pathology and Microbiology. 2022 (in-press). I.F. 0.74.
  19. Chandra K, Das AK, Banday S, Rana NA, Arora M, Jain S, Islam F, Agarwal S, Kashyap V, Joshi S, Mueed A, Dudeja M. Efficacy of polyherbal formulations for prevention of COVID-19 infection in high-risk subjects: A randomized open-label controlled clinical trial. Phytotherapy Research. 2022 Jul 5:10.1002/ptr.7531. doi: 10.1002/ptr.7531. I.F. 6.4
  20. Chandra K, Dudeja M, Aalam K. Asymptomatic SARS-COV-2 carriage and sero-positivity in high-risk contacts of COVID-19 cases. Indian Journal of Medical Microbiology. 2022. 40(2):279-284. I.F. 1.35
  21. Jain V, Jain SK, Chandra K*. Medicinal plants and phytochemicals in prevention and management of life style disorders: Pharmacological studies and challenges. Asian Journal of Pharmaceutical and Clinical Research. 2021; 14:1-6
  22. Jain V, Nabi N, Chandra K*, Irshad S, Kashyap V, Kohli S, Gupta A. A comparative analysis of COVID-19 mortality rate across the globe: An extensive analysis of the associated factors. Journal of epidemiology and public health. 2021. 06(03): 307-319
  23. Chandra K, Jain V, Jain SK. Plasma Non-Esterified Fatty Acids (NEFA) in Type 2 Diabetes Mellitus: Evidence on Pathophysiology. J Diabetes Clin Res. 2021; 3(2):46-50.
  24. Chandra K, Jain V, Azhar M, Khan W, Alam O, Ahmad S., Jain SK*. Effect of augmented glycation in mobilization of plasma free fatty acids in type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020; 14: 1385-1389.
  25. Reyaz A, Alam S, Chandra K*, Kohli S, Agarwal S. Methylglyoxal and soluble RAGE in type 2 diabetes mellitus: Association with oxidative stress. Journal of Diabetes & Metabolic Disorders.2020; 19:515–521. https://doi.org/10.1007/s40200-020-00543-y
  26. Kandpal C.G, , Kumar R., Chandra K. Pandey S, Bisht T. Prevalence of hepatitis B virus genotype and sub-genotype in north and east region of India: DNA sequencing methodology. Current Trends in Biotechnology and Pharmacy 2020; 14:147-155.
  27. Chandra K., Jain SK, and Dwivedi S. The Role of Herbal Plants for the Management of Diabetes Mellitus: A Review. Cardiology today 2020; 24:74-81.
  28. Chandra K., Jain V., Jabeen A., Dwivedi S., Joshi S., Ahmad S., and Jain S.K. Effect of Cichorium intybus seeds supplementation on the markers of glycemic control, oxidative stress, inflammation, and lipid profile in type 2 diabetes mellitus: A randomized, double-blind placebo study. Phytotherapy Research, 2020; 34(7): 1609-1618. I.F-4.09.
  29. . Chandra K, Singh P, Dwivedi S, Jain SK. Diabetes mellitus and oxidative stress: A co-relative and therapeutic approach. Journal of Clinical and Diagnostic Research 2019; 13(5):7-12. DOI: 10.7860/JCDR/2019/40628.12878.
  30. Balyan K, Sharma P, Chandra K, Agarwal S, and Jain SK. Oxidative stress is independent factor for end-stage renal disease in type 2 diabetes mellitus patients. Annals of National Academy of Medical Sciences. 2018;54(3):147-152
  31. Chandra K. and Iqbal J. Protein carbonylation in freshly diagnosed hypothyroidism is independent of thyrotropin levels. J Lab Med 2018. 42(5), pp. 177-181.
  32. Chandra K, Khan W, Jetley S, Ahmad S, Jain SK. Antidiabetic, toxicological, and metabolomic profling of aqueous extract of Cichorium intybus seeds. Phcog Mag 2018; 14:377-83.
  33. Juneja A, Dwivedi S, Srivastava DK, Chandra K. Insulin Resistance in young obese subjects and its relation to smoking (A Pilot Study). Ind J Clin Biochem. 2017 Mar;32(1):99-102.2016. doi:10.1007/s12291-016-0579-4
  34. Khursheed M., Chandra K., Srivastava DK. Incidence of non-structural protein (ns1) positivity & its Correlation with thrombocyte count & serum transaminase levels (dengue episode-2013: a retrospective study). Int J Pharm Bio Sci. 2014 ; 5 (3) : (B) 95 – 103
  35. . Chandra K., Upadhyay B, Khursheed M. A study on health status of Medical students based on their BMI and abdominal circumference. IJBAMR.2014;3:609-614

Memberships and Fellowships

  1. Association of Clinical Biochemist of India (Membership number (3901/LM/JOUR)
  2. Life member of National M.Sc. Medical Teacher Association (2016/LM/DL/BIOC/64
  3. Indian society of Atherosclerosis & International society of Atherosclerosis Research
  4. Indian society of Arthrosclerosis & Research-Delhi chapter (LM-52)
  5. Society for Ethnopharmacology (SFE- India), membership no- SFE/17/I-1028

Awards

  1. A Natural Phytochemical Dietary Supplement for Prevention, Treatment, and Management of Diabetes Mellitus. Complete Patent application filed on March 11, 2020. Applicant – Hamdard Institute of Medical Sciences and Research, Inventors – Kailash Chandra, Vineet Jain, Sayeed Ahmad and S. K. Jain. Patent application number: 201911009430.
  2. Certified Internal Auditor as per ISO15189:2022. Trained during 4 days training on Quality Management System and Internal Audit for Medical Testing Laboratories as per ISO 15189:2022 from August 27-30, 2024 at Hamdard Institute of Medical Sciences and Research, New Delhi.
  3. Selected and successfully completed the Department of Health Research sponsored training program on ‘Advent of Omics Technologies in Precision Diagnostics and Targeted Therapeutics” from April 15-May 7. 2024 (21 days) at ICMR-National Institute of Cancer Prevention and Research, Noida
  4. Successfully completed ‘Basic Course in Biomedical Research’ as mandated by National Medical Commission with a consolidated score of 73% (March- June 2020).
  5. Balaji Endowment Medal for Basic Experimental Research in Atherosclerosis given by Indian Society of atherosclerosis Research (ISARCON) during its 30th National Conference at AIIMS Patna dated 2nd -4 th November, 2017.
  6. SFE- young Ethnopharmacologist Award-2020 (P K Debnath Memorial Award) for best oral presentation in the field of Ethnopharmacology and Medicinal Plant Research. Research work was presented during 7th International Congress of the Society for Ethnopharmacology, India (SFEC-2020) at New Delhi, India (February 15-17, 2020).

Invited Talks and Lectures

  1. Invited speaker, delivered a Invited lecture entitled ‘Integrating millets into Diabetes Management: The Functional Potential of Eleusine Coracana’ during 12th International Conference of Society of Ethnopharmacology, India (SFEC-2025) at KLE academy of Higher Education and Research Centre at Belgavi, Karnataka , India on March 6-8, 2025.
  2. Speaker, Delivered a Invited lecture entitled ‘Exploring Medicinal Plants and Phytochemicals: Research and Therapy for Preventing and Managing Type 2 Diabetes Mellitus’ during North Zone ACBI Conference dated on February 1-2, 2024 organized by Department of Biochemistry, All India Institute of Medical Sciences and Research, Jodhpur, Rajasthan.
  3. Speaker, Delivered a lecture in Trainee Student Lecture Series of 2022 ( Title: Drug discovery and its development: AYUSH Perspective) held at SPER, organized by ‘Centre of Excellence of Unani Medicine (Pharmacognosy and Pharmacology), BNPL Jamia Hamdard, New Delhi on 19th- 22nd July 2022.
  4. Invited Speaker, 8th International Congress of Society for Ethnopharmacology, India SFEC 2021, organized by Bharti Vidyapeeth (Deemed To Be University), Poona College of Pharmacy, Pune, Maharashtra, INDIA held on August 27th to 29th, 2021.
  5. Speaker during the HIMSR, UNANI CONCLAVE on the occasion of World Unani Day 2021 at Hamdard Institute of Medical Sciences and Research dated on February 12, 2021.
  6. Invited Speaker, 9th International Congress of Society for Ethnopharmacology, India SFEC 2022 (Title: Medicinal Plants and their Phytochemicals: A potential candidate for research and therapy in prevention and management of type 2 diabetes mellitus), organized by JSS College of pharmacy, JSS Academy of higher Education & Research, Mysuru, Karnataka, INDIA held on April 22 to 24th, 2022.
  7. Invited Speaker, 32nd Annual conference and International Symposium of Indian Society for Atherosclerosis Resarch (ISARCON 2019), organized by Department of Biochemistry, Lady Harding Medical College, SSKH and KSCH, New Delhi, 2019.